Trial record 1 of 1 for:
FW2020-1
A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04731467 |
|
Recruitment Status :
Active, not recruiting
First Posted : February 1, 2021
Last Update Posted : April 4, 2024
|
Sponsor:
Famewave Ltd.
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Purple Biotech Ltd. ( Famewave Ltd. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2024 |
| Estimated Study Completion Date : | January 2025 |